PHE’s Shafrin and Linthicum Discuss Patient-Centered Formulary Challenges in Health Affairs

In a recent column in Health Affairs, Precision’s Jason Shafrin and Mark Linthicum address how value assessment frameworks are leading to more patient-centered formularies.

To read their post, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.